Myeloproliferative and myelodysplastic disease, unclassifiable (Q39206): Difference between revisions

← Older edit

@@ Property / CURIE @@
+CID11:2A44
@@ Property / CURIE: CID11:2A44 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-2A44
@@ Property / Canary Token: dki-india-2A44 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+C94.6
@@ Property / Linked ICD 10: C94.6 / rank @@
+Normal rank

Latest revision as of 04:32, 13 August 2026

This entity includes cases that have clinical, laboratory, and morphologic features that support the diagnosis of both a myelodysplastic syndrome and a myeloproliferative neoplasm, but do not meet the criteria for any of the other entities included in the myelodysplastic/myeloproliferative neoplasm category.

Language	Label	Description	Also known as
default for all languages	2A44
English	Myeloproliferative and myelodysplastic disease, unclassifiable	This entity includes cases that have clinical, laboratory, and morphologic features that support the diagnosis of both a myelodysplastic syndrome and a myeloproliferative neoplasm, but do not meet the criteria for any of the other entities included in the myelodysplastic/myeloproliferative neoplasm category.